Evotec inks li­cense agree­ment with J&J; On­colyt­ic virus biotech prices $15M IPO

3 years ago
News Briefing

Proflu­ent de­buts to de­sign pro­teins with ma­chine learn­ing in bid to move past 'AI sprin­kled on top'

3 years ago
Financing
Startups

In­vestor 'misalign­men­t' leads to tR­NA biotech's shut­ter­ing

3 years ago
People
Startups

Aridis' mon­o­clon­al an­ti­body fails PhI­II, but plans for sec­ond tri­al any­way

3 years ago
R&D

Xy­lo­Cor wraps up PhII for heart dis­ease gene ther­a­py, plans for piv­otal tri­al

3 years ago
R&D
Cell/Gene Tx

Abzena lays off more than 60 em­ploy­ees in Cal­i­for­nia

3 years ago
People
Manufacturing

#JPM23: What's re­al­ly dri­ving the cost of health­care and drugs in 2023?

3 years ago

Oral drug for di­a­bet­ic retinopa­thy flunks PhII, but biotech wants to go in­to PhI­II with new end­point

3 years ago
R&D

Grey Wolf reels in $49M to en­ter the clin­ic for new im­munother­a­py tar­get

3 years ago
Financing
Startups

Pa­tient death spurs tri­al halt for Ma­gen­ta Ther­a­peu­tics

3 years ago
R&D

FDA sends warn­ing let­ter to com­mu­ni­ty hos­pi­tal re­view board over re­search con­cerns

3 years ago
Pharma
FDA+

Har­ris Poll breaks down #JPM23 con­fer­ence’s hottest top­ics and pop­u­lar peo­ple among in­dus­try ex­perts

3 years ago
Marketing

Mer­ck halts prostate can­cer study while re­port­ing pos­i­tive read­out in bil­iary tract can­cer

3 years ago
R&D
Pharma

Lon­za posts full 2022 re­sults as it looks to buy back $2B+ in shares

3 years ago
Pharma
Manufacturing

No­var­tis re-en­lists spokescelebri­ty Ken Jeong for Xi­idra movie trail­er spoof cam­paign

3 years ago
Pharma
Marketing

NIH as­so­ciate di­rec­tor an­nounces de­par­ture to pri­vate sec­tor, join­ing an­ti-ag­ing biotech

3 years ago
People

Gener­ic abor­tion drug man­u­fac­tur­er sues West Vir­ginia over re­stric­tions

3 years ago
Law

EMA changes or­phan des­ig­na­tion pol­i­cy for cer­tain eye drugs to ex­pand ac­cess

3 years ago
Pharma
FDA+

Sanofi takes to Tik­Tok and In­sta­gram to tar­get mil­len­ni­als and old­er Gen Z par­ents for RSV ed­u­ca­tion

3 years ago
Pharma
Marketing

FDA ad­comm votes in fa­vor of new an­ti­fun­gal; De­nali gets $25M from Sanofi MS tri­al mile­stone

3 years ago
R&D
News Briefing

More da­ta, more dol­lars: Three biotechs post of­fer­ings af­ter tri­al read­outs

3 years ago
Financing

Neu­ralink em­ploy­ees cite lay­offs at Elon Musk’s brain-com­put­er in­ter­face start­up

3 years ago
People
Startups

ODAC to de­bate Roche's Po­livy in first-line DL­B­CL fol­low­ing 2019 ac­cel­er­at­ed ap­proval

3 years ago
FDA+

J&J qui­et­ly punts a pair of ear­ly-stage bis­pecifics for sol­id tu­mors

3 years ago
R&D
Pharma
First page Previous page 385386387388389390391 Next page Last page
A service from the Financial Times